{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:10:56Z","timestamp":1790730656850,"version":"4.1.0"},"publisher-location":"Cham","reference-count":79,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031598142","type":"print"},{"value":"9783031598159","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-59815-9_27","type":"book-chapter","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:01:55Z","timestamp":1723154515000},"page":"399-408","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Macrophage Activation Syndrome in the Setting of Rheumatic Diseases"],"prefix":"10.1007","author":[{"given":"W. Winn","family":"Chatham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"issue":"4","key":"27_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.semarthrit.2015.07.004","volume":"45","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n P, Bosch X, P\u00e9rez-de-Lis M, et al. Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies. Semin Arthritis Rheum. 2016;45(4):391\u20139.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"27_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/RHU.0b013e3181d569e1","volume":"16","author":"A Collamer","year":"2010","unstructured":"Collamer A, Arroyo R. Bone marrow hemophagocytosis complicating rheumatoid arthritis. J Clin Rheumatol. 2010;16(3):151.","journal-title":"J Clin Rheumatol"},{"issue":"11","key":"27_CR3","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S0248-8663(04)00269-3","volume":"25","author":"A Niang","year":"2004","unstructured":"Niang A, Diallo S, Ka MM, Pouye A, Diop S, Ndongo S, Diop TM. Hemophagocytic syndrome complicating adult\u2019s seropositive rheumatoid arthritis. Rev Med Interne. 2004;25(11):826\u20138.","journal-title":"Rev Med Interne"},{"issue":"10","key":"27_CR4","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1093\/rheumatology\/keq201","volume":"49","author":"M Ricci","year":"2010","unstructured":"Ricci M, Rossi P, De Marco G, Varisco V, Marchesoni A. Macrophage activation syndrome after leflunomide treatment in an adult rheumatoid arthritis patient. Rheumatology (Oxford). 2010;49(10):2001.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"27_CR5","first-page":"241","volume":"34","author":"C Sandhu","year":"2007","unstructured":"Sandhu C, Chesney A, Piliotis E, Buckstein R, Koren S. Macrophage activation syndrome after etanercept treatment. J Rheumatol. 2007;34(1):241\u20132.","journal-title":"J Rheumatol"},{"issue":"4","key":"27_CR6","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jbspin.2015.01.018","volume":"82","author":"M Leroy","year":"2015","unstructured":"Leroy M, Coiffier G, Pronier C, Triquet L, Perdriger A, Guggenbuhl P. Macrophage activation syndrome with acute hepatitis E during tocilizumab treatment for rheumatoid arthritis. Joint Bone Spine. 2015;82(4):278\u20139.","journal-title":"Joint Bone Spine"},{"issue":"6","key":"27_CR7","first-page":"1218","volume":"25","author":"J Sibilia","year":"1998","unstructured":"Sibilia J, Javier RM, Albert A, Cazenave JP, Kuntz JL. Pancytopenia secondary to hemophagocytic syndrome in rheumatoid arthritis treated with methotrexate and sulfasalazine. J Rheumatol. 1998;25(6):1218\u201320.","journal-title":"J Rheumatol."},{"issue":"3","key":"27_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jbspin.2010.01.011","volume":"77","author":"A Molt\u00f3","year":"2010","unstructured":"Molt\u00f3 A, Mateo L, Lloveras N, Oliv\u00e9 A, Minguez S. Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab. Joint Bone Spine. 2010;77(3):271\u20133.","journal-title":"Joint Bone Spine"},{"issue":"2","key":"27_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000312628","volume":"153","author":"S Deane","year":"2010","unstructured":"Deane S, Selmi C, Teuber SS, Gershwin ME. Macrophage activation syndrome in autoimmune disease. Int Arch Allergy Immunol. 2010;153(2):109\u201320.","journal-title":"Int Arch Allergy Immunol"},{"issue":"10","key":"27_CR10","first-page":"1414","volume":"16","author":"M Atteritano","year":"2012","unstructured":"Atteritano M, David A, Bagnato G, Beninati C, Frisina A, Iaria C, Bagnato G, Cascio A. Haemophagocytic syndrome in rheumatic patients. A systematic review. Eur Rev Med Pharmacol Sci. 2012;16(10):1414\u201324.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"27_CR11","doi-asserted-by":"publisher","first-page":"781100","DOI":"10.3389\/fimmu.2021.781100","volume":"12","author":"K Suhre","year":"2022","unstructured":"Suhre K, Sarwath H, Engelke R, Sohail MU, Cho SJ, Whalen W, Alvarez-Mulett S, Krumsiek J, Choi AMK, Schmidt F. Identification of robust protein associations with COVID-19 disease based on five clinical studies. Front Immunol. 2022;12:781100. https:\/\/doi.org\/10.3389\/fimmu.2021.781100. eCollection 2021","journal-title":"Front Immunol"},{"issue":"12","key":"27_CR12","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.3390\/cells10123291","volume":"10","author":"S Dewanjee","year":"2021","unstructured":"Dewanjee S, Kandimalla R, Kalra RS, Valupadas C, Vallamkondu J, Kolli V, Dey Ray S, Reddy AP, Reddy PH. COVID-19 and rheumatoid arthritis crosstalk: emerging association, therapeutic options and challenges. Cells. 2021;10(12):3291. https:\/\/doi.org\/10.3390\/cells10123291.","journal-title":"Cells"},{"issue":"11","key":"27_CR13","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s10067-007-0538-9","volume":"26","author":"YJ Lou","year":"2007","unstructured":"Lou YJ, Jin J, Mai WY. Ankylosing spondylitis presenting with macrophage activation syndrome. Clin Rheumatol. 2007;26(11):1929\u201330.","journal-title":"Clin Rheumatol"},{"issue":"10","key":"27_CR14","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3345\/kjp.2016.59.10.421","volume":"59","author":"JH Park","year":"2016","unstructured":"Park JH, Seo YM, Han SB, Kim KH, Rhim JW, Chung NG, Kim MS, Kang JH, Jeong DC. Recurrent macrophage activation syndrome since toddler age in an adolescent boy with HLA B27 positive juvenile ankylosing spondylitis. Korean J Pediatr. 2016;59(10):421\u20134.","journal-title":"Korean J Pediatr"},{"key":"27_CR15","unstructured":"Filocamo G, Petaccia A, Torcoletti M, Sieni E, Ravelli A, Corona F. Recurrent macrophage activation syndrome in spondyloarthritis and monoallelic missense mutations in PRF1: a description of one paediatric case. Clin Exp Rheumatol. 2016;34(4):719."},{"issue":"5","key":"27_CR16","first-page":"953","volume":"34","author":"RQ Cron","year":"2016","unstructured":"Cron RQ, Chatham WW. Development of spondyloarthropathy following episodes of macrophage activation syndrome in children with heterozygous mutations in haemophagocytic lymphohistiocytosis-associated genes. Clin Exp Rheumatol. 2016;34(5):953.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"27_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jbspin.2012.06.022","volume":"80","author":"V Andr\u00e9","year":"2013","unstructured":"Andr\u00e9 V, Liddell C, Guimard T, Tanguy G, Cormier G. Macrophage activation syndrome revealing disseminated tuberculosis in a patient on infliximab. Joint Bone Spine. 2013;80(1):109\u201310.","journal-title":"Joint Bone Spine"},{"key":"27_CR18","doi-asserted-by":"crossref","unstructured":"Troncoso Mari\u00f1o A, Campelo S\u00e1nchez E, et al. Haemophagocytic syndrome and paradoxical reaction to tuberculostatics after treatment with infliximab. Pharm World Sci. 2010;32(2):117\u20139.","DOI":"10.1007\/s11096-010-9369-x"},{"issue":"11","key":"27_CR19","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/apt.12305","volume":"37","author":"W Fries","year":"2013","unstructured":"Fries W, Cottone M, Cascio A. Systematic review: macrophage activation syndrome in inflammatory bowel disease. Aliment Pharmacol Ther. 2013;37(11):1033\u201345.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"27_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s42358-021-00204-5","volume":"61","author":"P Ruscitti","year":"2021","unstructured":"Ruscitti P, Conforti A, Cipriani P, Giacomelli R, Tasso M, Costa L, Caso F. Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders. Adv Rheumatol. 2021;61(1):45. https:\/\/doi.org\/10.1186\/s42358-021-00204-5.","journal-title":"Adv Rheumatol"},{"key":"27_CR21","first-page":"30186","volume":"18","author":"P S\u00e1nchez-Moreno","year":"2018","unstructured":"S\u00e1nchez-Moreno P, Olbrich P, Falc\u00f3n-Neyra L, Lucena JM, Aznar J, Neth O. Typhoid fever causing haemophagocytic lymphohistiocytosis in a non-endemic country \u2013 first case report and review of the current literature. Enferm Infecc Microbiol Clin. 2018;18:30186\u20131.","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"4","key":"27_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1179\/acb.2010.059","volume":"65","author":"I Ramon","year":"2010","unstructured":"Ramon I, Libert M, Guillaume MP, Corazza F, Karmali R. Recurrent haemophagocytic syndrome in an HIV-infected patient. Acta Clin Belg. 2010;65(4):276\u20138.","journal-title":"Acta Clin Belg"},{"issue":"5","key":"27_CR23","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/art.11368","volume":"49","author":"R Dhote","year":"2003","unstructured":"Dhote R, Simon J, Papo T, et al. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum. 2003;49(5):633\u20139.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"27_CR24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00296-005-0024-0","volume":"26","author":"I Hayakawa","year":"2006","unstructured":"Hayakawa I, Shirasaki F, Ikeda H, Oishi N, Hasegawa M, Sato S, Takehara K. Reactive hemophagocytic syndrome in a patient with polyarteritis nodosa associated with Epstein-Barr virus reactivation. Rheumatol Int. 2006;26(6):573\u20136.","journal-title":"Rheumatol Int"},{"issue":"6","key":"27_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29461","volume":"69","author":"VV Iyengar","year":"2022","unstructured":"Iyengar VV, Chougule A, Gowri V, Taur P, Prabhu S, Bodhanwala M, Desai MM. DADA2 presenting as nonimmune hemolytic anemia with recurrent macrophage activation syndrome. Pediatr Blood Cancer. 2022;69(6):e29461. https:\/\/doi.org\/10.1002\/pbc.29461.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"27_CR26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-2257.2005.00728.x","volume":"27","author":"A Aleem","year":"2005","unstructured":"Aleem A, Al Amoudi S, Al-Mashhadani S, Siddiqui N. Haemophagocytic syndrome associated with hepatitis-B virus infection responding to etoposide. Clin Lab Haematol. 2005;27(6):395\u20138.","journal-title":"Clin Lab Haematol"},{"key":"27_CR27","doi-asserted-by":"publisher","first-page":"bcr2016214655","DOI":"10.1136\/bcr-2016-214655","volume":"2016","author":"MG Yu","year":"2016","unstructured":"Yu MG, Chua. Virus-associated haemophagocytic lymphohistiocytosis in a young Filipino man. J BMJ Case Rep. 2016;2016:bcr2016214655.","journal-title":"J BMJ Case Rep"},{"issue":"2","key":"27_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/(SICI)1096-8652(199906)61:2<135::AID-AJH11>3.0.CO;2-E","volume":"61","author":"M Faurschou","year":"1999","unstructured":"Faurschou M, Nielsen OJ, Hansen PB, Juhl BR, Hasselbalch H. Fatal virus-associated hemophagocytic syndrome associated with coexistent chronic active hepatitis B and acute hepatitis C virus infection. Am J Hematol. 1999;61(2):135\u20138.","journal-title":"Am J Hematol"},{"issue":"2","key":"27_CR29","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/SMJ.0b013e31802b2812","volume":"100","author":"Z Wang","year":"2007","unstructured":"Wang Z, Duarte AG, Schnadig VJ. Fatal reactive hemophagocytosis related to disseminated histoplasmosis with endocarditis: an unusual case diagnosed at autopsy. South Med J. 2007;100(2):208\u201311.","journal-title":"South Med J"},{"key":"27_CR30","first-page":"9263537","volume":"2018","author":"A Amlani","year":"2018","unstructured":"Amlani A, Bromley A, Fifi-Mah A. ANCA vasculitis and hemophagocytic lymphohistiocytosis following a fecal microbiota transplant. Case Rep Rheumatol. 2018;2018:9263537.","journal-title":"Case Rep Rheumatol"},{"key":"27_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s15010-010-0037-9","volume":"38","author":"A Cusini","year":"2010","unstructured":"Cusini A, Gunthard HF, Stussi G, et al. Hemophagocytic syndrome caused by primary herpes simplex virus 1 infection: report of a first case. Infection. 2010;38:423\u20136.","journal-title":"Infection"},{"issue":"15","key":"27_CR32","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S0025-7753(00)71633-2","volume":"115","author":"A Garc\u00eda Escudero","year":"2000","unstructured":"Garc\u00eda Escudero A, Ben\u00edtez Moya JM, Lag AE. Hemophagocytic syndrome and invasive aspergillosis in a patient with Churg-Strauss vasculitis. Med Clin (Barc). 2000;115(15):598.","journal-title":"Med Clin (Barc)"},{"key":"27_CR33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.12659\/AJCR.891067","volume":"15","author":"A Basnet","year":"2014","unstructured":"Basnet A, Cholankeril MR. Hemophagocytic lymphohistiocytosis in a patient with Goodpasture\u2019s syndrome: a rare clinical association. Am J Case Rep. 2014;15:431\u20136.","journal-title":"Am J Case Rep"},{"issue":"1","key":"27_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12969-022-00727-1","volume":"20","author":"MC Bryant","year":"2022","unstructured":"Bryant MC, Spencer LT, Yalcindag A. A case of ANCA-associated vasculitis in a 16-year-old female following SARS-COV-2 infection and a systematic review of the literature. Pediatr Rheumatol Online J. 2022;20(1):65. https:\/\/doi.org\/10.1186\/s12969-022-00727-1.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"11","key":"27_CR35","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1016\/j.ekir.2020.08.012","volume":"5","author":"NN Uppal","year":"2020","unstructured":"Uppal NN, Kello N, Shah HH, Khanin Y, De Oleo IR, Epstein E, Sharma P, Larsen CP, Bijol V, Jhaveri KD. De Novo ANCA-associated vasculitis with glomerulonephritis in COVID-19. Kidney Int Rep. 2020;5(11):2079\u201383.","journal-title":"Kidney Int Rep"},{"issue":"6","key":"27_CR36","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/MPH.0000000000000872","volume":"39","author":"S Garc\u00eda-Pav\u00f3n","year":"2017","unstructured":"Garc\u00eda-Pav\u00f3n S, Yamazaki-Nakashimada MA, B\u00e1ez M, Borjas-Aguilar KL, Murata C. Kawasaki disease complicated with macrophage activation syndrome: a systematic review. J Pediatr Hematol Oncol. 2017;39(6):445\u201351.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"27_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.semarthrit.2014.07.007","volume":"44","author":"W Wang","year":"2015","unstructured":"Wang W, Gong F, Zhu W, Fu S, Zhang Q. Macrophage activation syndrome in Kawasaki disease: more common than we thought? Semin Arthritis Rheum. 2015;44(4):405\u201310.","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"27_CR38","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/ATVBAHA.115.306475","volume":"35","author":"Y Lee","year":"2015","unstructured":"Lee Y, Wakita D, Dagvadorj J, et al. IL-1 signaling is critically required in stromal cells in Kawasaki disease vasculitis mouse model: role of both IL-1\u03b1 and IL-1\u03b2. Arterioscler Thromb Vasc Biol. 2015;35(12):2605\u201316.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"27_CR39","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1161\/CIRCULATIONAHA.111.072769","volume":"125","author":"Y Lee","year":"2012","unstructured":"Lee Y, Schulte DJ, Shimada K, et al. Interleukin-1\u03b2 is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease. Circulation. 2012;125(12):1542\u201350.","journal-title":"Circulation"},{"key":"27_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fphar.2017.00163","volume":"8","author":"P Dusser","year":"2017","unstructured":"Dusser P, Kon\u00e9-Paut I. IL-1 inhibition may have an important role in treating refractory Kawasaki disease. Front Pharmacol. 2017;8:163.","journal-title":"Front Pharmacol"},{"issue":"2","key":"27_CR41","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/art.39975","volume":"69","author":"JC Burns","year":"2017","unstructured":"Burns JC, Kone-Paut I, Kuijpers T. Review: found in translation: international initiatives pursuing interleukin-1 blockade for treatment of acute Kawasaki disease. Arthritis Rheumatol. 2017;69(2):268\u201376.","journal-title":"Arthritis Rheumatol"},{"key":"27_CR42","doi-asserted-by":"publisher","first-page":"787353","DOI":"10.3389\/fped.2021.787353","volume":"9","author":"MM Kostik","year":"2021","unstructured":"Kostik MM, Bregel LV, Avrusin IS, Dondurei EA, Matyunova AE, Efremova OS, Isupova EA, Kornishina TL, Masalova VV, Snegireva LS, Shprakh VV, Kozlov YA, Kalashnikova OV, Chasnyk VG. Distinguishing between multisystem inflammatory syndrome, associated with covid-19 in children and the kawasaki disease: development of preliminary criteria based on the data of the Retrospective Multicenter Cohort Study. Front Pediatr. 2021;9:787353. https:\/\/doi.org\/10.3389\/fped.2021.787353.","journal-title":"Front Pediatr"},{"key":"27_CR43","doi-asserted-by":"publisher","first-page":"981711","DOI":"10.3389\/fped.2022.981711","volume":"10","author":"P Buda","year":"2022","unstructured":"Buda P, Strauss E, Januszkiewicz-Lewandowska D, Czerwinska E, Ludwikowska K, Szenborn L, Gowin E, Okarska-Napiera\u0142a M, Kuchar E, Ksia ZJ. Clinical characteristics of children with MIS-C fulfilling classification criteria for macrophage activation syndrome. Front Pediatr. 2022;10:981711. https:\/\/doi.org\/10.3389\/fped.2022.981711.","journal-title":"Front Pediatr"},{"issue":"5","key":"27_CR44","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/children9050672","volume":"9","author":"G Bossi","year":"2022","unstructured":"Bossi G, Codazzi AC, Vinci F, Clerici E, Regalbuto C, Crapanzano C, Veraldi D, Moiraghi A, Marseglia GL. Efficacy of anakinra on multiple coronary arteries aneurysms in an infant with recurrent Kawasaki disease, complicated by macrophage activation syndrome. Children (Basel). 2022;9(5):672. https:\/\/doi.org\/10.3390\/children9050672.","journal-title":"Children (Basel)"},{"issue":"2","key":"27_CR45","doi-asserted-by":"publisher","first-page":"e381","DOI":"10.1097\/RHU.0000000000001734","volume":"28","author":"E \u00c7elikel","year":"2022","unstructured":"\u00c7elikel E, Tekin ZE, Aydin F, Emeksiz S, Uyar E, \u00d6zcan S, Perk O, Sezer M, Tekg\u00f6z N, Co\u015fkun S, G\u00fcng\u00f6rer V, G\u00fcl AEK, Bayhan G\u0130, \u00d6zbek N, Azili MN, Acar B\u00c7. Role of biological agents in the treatment of SARS-CoV-2-associated multisystem inflammatory syndrome in children. J Clin Rheumatol. 2022;28(2):e381\u20137. https:\/\/doi.org\/10.1097\/RHU.0000000000001734.","journal-title":"J Clin Rheumatol"},{"key":"27_CR46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.clim.2016.05.010","volume":"169","author":"N Inoue","year":"2016","unstructured":"Inoue N, Shimizu M, Tsunoda S, Kawano M, et al. Cytokine profile in adult-onset Still\u2019s disease: comparison with systemic juvenile idiopathic arthritis. Clin Immunol. 2016;169:8\u201313.","journal-title":"Clin Immunol"},{"issue":"12","key":"27_CR47","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1007\/s10067-017-3830-3","volume":"36","author":"P Ruscitti","year":"2017","unstructured":"Ruscitti P, Rago C, Breda L, et al. Macrophage activation syndrome in Still\u2019s disease: analysis of clinical characteristics and survival in paediatric and adult patients. Clin Rheumatol. 2017;36(12):2839\u201345.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"27_CR48","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.semarthrit.2015.11.002","volume":"45","author":"A Lenert","year":"2016","unstructured":"Lenert A, Yao Q. Macrophage activation syndrome complicating adult onset Still\u2019s disease: a single center case series and comparison with literature. Semin Arthritis Rheum. 2016;45(6):711\u20136.","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"27_CR49","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/1744666X.2017.1332994","volume":"13","author":"DH Yoo","year":"2017","unstructured":"Yoo DH. Treatment of adult-onset Still\u2019s disease: up to date. Expert Rev Clin Immunol. 2017;13(9):849\u201366.","journal-title":"Expert Rev Clin Immunol"},{"issue":"24","key":"27_CR50","doi-asserted-by":"publisher","first-page":"e6656","DOI":"10.1097\/MD.0000000000006656","volume":"96","author":"F Parisi","year":"2017","unstructured":"Parisi F, Paglionico A, Varriano V, et al. Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis: a case report treated with high doses (8\u200amg\/kg\/d) of Anakinra. Medicine (Baltimore). 2017;96(24):e6656.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"27_CR51","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3899\/jrheum.121098","volume":"40","author":"PJ Kahn","year":"2013","unstructured":"Kahn PJ, Cron RQ. Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome. J Rheumatol. 2013;40(5):743\u20134.","journal-title":"J Rheumatol"},{"key":"27_CR52","doi-asserted-by":"publisher","first-page":"5656320","DOI":"10.1155\/2016\/5656320","volume":"2016","author":"E Watanabe","year":"2016","unstructured":"Watanabe E, Sugawara H, Yamashita T, et al. Successful tocilizumab therapy for macrophage activation syndrome associated with adult-onset Still\u2019s disease: a case-based review. Case Rep Med. 2016;2016:5656320.","journal-title":"Case Rep Med"},{"issue":"1","key":"27_CR53","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1086\/685112","volume":"6","author":"MV Mehta","year":"2016","unstructured":"Mehta MV, Manson DK, Horn EM, Haythe J. An atypical presentation of adult-onset Still\u2019s disease complicated by pulmonary hypertension and macrophage activation syndrome treated with immunosuppression: a case-based review of the literature. Pulm Circ. 2016;6(1):136\u201342.","journal-title":"Pulm Circ"},{"issue":"7","key":"27_CR54","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/rheumatology\/keu019","volume":"53","author":"E Savage","year":"2014","unstructured":"Savage E, Wazir T, Drake M, et al. Fulminant myocarditis and macrophage activation syndrome secondary to adult-onset Still\u2019s disease successfully treated with tocilizumab. Rheumatology (Oxford). 2014;53(7):1352\u20133.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"27_CR55","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000068888","volume":"206","author":"E Alpsoy","year":"2003","unstructured":"Alpsoy E, Kodelja V, Goerdt S, et al. Serum of patients with Beh\u00e7et\u2019s disease induces classical (pro-inflammatory) activation of human macrophages in vitro. Dermatology. 2003;206(3):225\u201332.","journal-title":"Dermatology"},{"issue":"5","key":"27_CR56","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/rheumatology\/35.5.424","volume":"35","author":"S Sahin","year":"1996","unstructured":"Sahin S, Lawrence R, Direskeneli H, et al. Monocyte activity in Beh\u00e7et\u2019s disease. Br J Rheumatol. 1996;35(5):424\u20139.","journal-title":"Br J Rheumatol"},{"issue":"1","key":"27_CR57","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3109\/08830189709116841","volume":"14","author":"N Yamashita","year":"1997","unstructured":"Yamashita N. Hyperreactivity of neutrophils and abnormal T cell homeostasis: a new insight for pathogenesis of Beh\u00e7et\u2019s disease. Int Rev Immunol. 1997;14(1):11\u20139.","journal-title":"Int Rev Immunol"},{"key":"27_CR58","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1080\/03009740510015186","volume":"34","author":"SH Lee","year":"2005","unstructured":"Lee SH, Kim SD, Kim SH, et al. EBV-associated haemophagocytic syndrome in a patient with Behcet\u2019s disease. Scand J Rheumatol. 2005;34:320\u20133.","journal-title":"Scand J Rheumatol"},{"issue":"8","key":"27_CR59","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s10067-015-2923-0","volume":"34","author":"D Rigante","year":"2015","unstructured":"Rigante D, Emmi G, Fastiggi M, et al. Macrophage activation syndrome in the course of monogenic autoinflammatory disorders. Clin Rheumatol. 2015;34(8):1333\u20139.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"27_CR60","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/acr.20418","volume":"63","author":"L Rossi-Semerano","year":"2011","unstructured":"Rossi-Semerano L, Hermeziu B, Fabre M, Kon\u00e9-Paut I. Macrophage activation syndrome revealing familial Mediterranean fever. Arthritis Care Res (Hoboken). 2011;63(5):780\u20133.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3 Suppl 77","key":"27_CR61","first-page":"99","volume":"31","author":"G Horneff","year":"2013","unstructured":"Horneff G, Rhouma A, Weber C, Lohse P. Macrophage activation syndrome as the initial manifestation of tumour necrosis factor receptor 1-associated periodic syndrome (TRAPS). Clin Exp Rheumatol. 2013;31(3 Suppl 77):99\u2013102.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"27_CR62","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/art.22409","volume":"56","author":"D Rigante","year":"2007","unstructured":"Rigante D, Capoluongo E, Bertoni B. First report of macrophage activation syndrome in hyperimmunoglobulinemia D with periodic fever syndrome. Arthritis Rheum. 2007;56(2):658\u201361.","journal-title":"Arthritis Rheum"},{"issue":"6 Suppl 102","key":"27_CR63","first-page":"S115","volume":"34","author":"FK Eroglu","year":"2016","unstructured":"Eroglu FK, Kasapcopur O, Be\u015fba\u015f N. Genetic and clinical features of cryopyrin-associated periodic syndromes in Turkish children. Clin Exp Rheumatol. 2016;34(6 Suppl 102):S115\u201320.","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"27_CR64","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/ng.3089","volume":"46","author":"SW Canna","year":"2014","unstructured":"Canna SW, de Jesus AA, Gouni S, et al. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet. 2014;46(10):1140\u20136.","journal-title":"Nat Genet"},{"issue":"4","key":"27_CR65","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1172\/JCI129301","volume":"130","author":"AA de Jesus","year":"2020","unstructured":"de Jesus AA, Hou Y, Brooks S, Malle L, Goldbach-Mansky R, et al. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases. J Clin Invest. 2020;130(4):1669\u201382. https:\/\/doi.org\/10.1172\/JCI129301.","journal-title":"J Clin Invest"},{"issue":"7","key":"27_CR66","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00296-020-04590-9","volume":"40","author":"D Kishida","year":"2020","unstructured":"Kishida D, Sakaguchi N, Ueno KI, Ushiyama S, Ichikawa T, Yoshinaga T, Shimojima Y, Sekijima Y. Macrophage activation syndrome in adult dermatomyositis: a case-based review. Rheumatol Int. 2020;40(7):1151\u201362. https:\/\/doi.org\/10.1007\/s00296-020-04590-9.","journal-title":"Rheumatol Int"},{"issue":"11","key":"27_CR67","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.autrev.2014.05.009","volume":"13","author":"D Poddighe","year":"2014","unstructured":"Poddighe D, Cavagna L, Brazzelli V, et al. A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: a challenging clinical case in light of the current diagnostic criteria. Autoimmun Rev. 2014;13(11):1142\u20138.","journal-title":"Autoimmun Rev"},{"key":"27_CR68","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12969-015-0048-2","volume":"13","author":"H Wakiguchi","year":"2015","unstructured":"Wakiguchi H, Hasegawa S, Hirano R, et al. Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and -18 levels. Pediatr Rheumatol Online J. 2015;13:49.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"27_CR69","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/03009742.2013.863968","volume":"43","author":"V Lilleby","year":"2014","unstructured":"Lilleby V, Haydon J, Sanner H, et al. Severe macrophage activation syndrome and central nervous system involvement in juvenile dermatomyositis. Scand J Rheumatol. 2014;43(2):171\u20133.","journal-title":"Scand J Rheumatol"},{"key":"27_CR70","doi-asserted-by":"crossref","unstructured":"Kaieda S, Yoshida N, Yamashita F. Successful treatment of macrophage activation syndrome in a patient with dermatomyositis by combination with immunosuppressive therapy and plasmapheresis. Mod Rheumatol. 2015;25(6):962\u20136.","DOI":"10.3109\/14397595.2013.844402"},{"issue":"1","key":"27_CR71","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.anpedi.2011.12.011","volume":"77","author":"BR Bustos","year":"2012","unstructured":"Bustos BR, Carrasco AC, Toledo RC. Plasmapheresis for macrophage activation syndrome and multiorgan failure as first presentation of juvenile dermatomyositis. An Pediatr (Barc). 2012;77(1):47\u201350.","journal-title":"An Pediatr (Barc)"},{"key":"27_CR72","doi-asserted-by":"crossref","unstructured":"Lange AV, Kazi S, Chen W, Barnes A. Fatal case of macrophage activation syndrome (MAS) in a patient with dermatomyositis and cytomegalovirus (CMV) viraemia. BMJ Case Rep. 2018;pii: bcr-2018-225231","DOI":"10.1136\/bcr-2018-225231"},{"issue":"2","key":"27_CR73","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/RHU.0000000000000512","volume":"23","author":"N Hone","year":"2017","unstructured":"Hone N, Donnelly C, Houk JB, Mina R. Macrophage activation syndrome in scleroderma. J Clin Rheumatol. 2017;23(2):120\u20131.","journal-title":"J Clin Rheumatol"},{"issue":"3","key":"27_CR74","first-page":"659","volume":"41","author":"A Tochimoto","year":"2001","unstructured":"Tochimoto A, Nishimagi E, Kawaguchi Y, et al. A case of recurrent hemophagocytic syndrome complicated with systemic sclerosis: relationship between disease activity and serum level of IL-18. Ryumachi. 2001;41(3):659\u201364.","journal-title":"Ryumachi"},{"issue":"5","key":"27_CR75","first-page":"820","volume":"42","author":"Y Katsumata","year":"2002","unstructured":"Katsumata Y, Okamoto H, Harigai M, Ota S, Uesato M, Tochimoto A, Kawaguchi Y, Terai C, Hara M, Kamatani N. Etoposide ameliorated refractory hemophagocytic syndrome in a patient with systemic sclerosis. Ryumachi. 2002;42(5):820\u20136.","journal-title":"Ryumachi"},{"issue":"6","key":"27_CR76","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4929","volume":"11","author":"S Kasparian","year":"2019","unstructured":"Kasparian S, Anand K, Burns E, Chung B, Pingali SRK. Macrophage activation syndrome secondary to underlying sarcoidosis. Cureus. 2019;11(6):e4929. https:\/\/doi.org\/10.7759\/cureus.4929.","journal-title":"Cureus"},{"issue":"1","key":"27_CR77","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/ejh.12886","volume":"99","author":"AB Schulze","year":"2017","unstructured":"Schulze AB, Heptner B, Kessler T, et al. Progressive histoplasmosis with hemophagocytic lymphohistiocytosis and epithelioid cell granulomatosis: a case report and review of the literature. Eur J Haematol. 2017;99(1):91\u2013100.","journal-title":"Eur J Haematol"},{"issue":"1","key":"27_CR78","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2500\/aap.2014.35.3704","volume":"35","author":"P Bajaj","year":"2014","unstructured":"Bajaj P, Clement J, Bayerl MG, et al. High-grade fever and pancytopenia in an adult patient with common variable immune deficiency. Allergy Asthma Proc. 2014;35(1):78\u201382.","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"27_CR79","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1089\/vim.2011.0060","volume":"25","author":"A Aghamohammadi","year":"2012","unstructured":"Aghamohammadi A, Abolhassani H, Hirbod-Mobarakeh A, et al. The uncommon combination of common variable immunodeficiency, macrophage activation syndrome, and cytomegalovirus retinitis. A. Viral Immunol. 2012;25(2):161\u20135.","journal-title":"Viral Immunol"}],"container-title":["Advances in Experimental Medicine and Biology","Cytokine Storm Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-59815-9_27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:06:20Z","timestamp":1723154780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-59815-9_27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031598142","9783031598159"],"references-count":79,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-59815-9_27","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"9 August 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}